Author

Nahid Irani

Northwestern University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Bakare AwakoaiyeiD· 2 shared Pablo Penaloza‐MacMasteriD· 2 shared Sarah SancheziD· 2 shared Tanushree DangiiD· 2 shared Gabriel ArellanoiD· 1 shared Justin Richner· 1 shared Laura Arroyo· 1 shared Malika AïdiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Bakare AwakoaiyeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Dosing and Serostatus Shape the Efficacy of Adenovirus, mRNA, and Protein Vaccines

Bakare Awakoaiye, Shiyi Li, Sarah Sanchez, Tanushree Dangi, Nahid Irani, Laura Arroyo, Gabriel Arellano, Shadi Mohammadabadi, Malika Aïd, Pablo Penaloza‐MacMaster

This study compares the immunological profiles and protective efficacy of Ad5, mRNA, and protein vaccines in mice, showing differences in antigen kinetics, immune responses, and performance based on serostatus and dosing regimen.

bioRxiv · Jul 16, 2025 · PreprintImmunology

Time-dependent enhancement of mRNA vaccines by 4-1BB costimulation

Sarah Sanchez, Tanushree Dangi, Bakare Awakoaiye, Nahid Irani, Slim Fourati, Justin Richner, Pablo Penaloza‐MacMaster

This study shows that administering 4-1BB costimulatory antibodies after 96 hours post-mRNA vaccination enhances CD8 T cell responses and protection against breakthrough infections.

Journal of Clinical Investigation · Oct 21, 2024Peer-reviewedImmunology